Fabio Efficace, PhD^1*, Gerwin A. Huls, MD, PhD², Michal Kicinski^3*, Walter JFM Van Der Velden⁴, Richard Noppeney, MD^5*, Sylvain Chantepie, MD^6*, Laimonas Griskevicius, MD, PhD^7*, Andreas Neubauer, MD⁸, Ernesta Audisio^9*, Mario Luppi^10*, Stephan Fuhrmann, M.D.^11*, Robin Foà^12*, Martina Crysandt, MD^13*, Gianluca Gaidano, MD, PhD¹⁴, Radovan Vrhovac, MD, PhD^15*, Adriano Venditti, MD¹⁶, Eduardus F.M. Posthuma, MD, PhD¹⁷, Anna Candoni, MD^18*, Frederic Baron¹⁹, Olivier Legrand, MD, PhD^20*, Andrea Mengarelli, MD^21*, Marco Vignetti, MD^1*, Anne Giraut, PhD^3*, Corneel Coens^3*, Stefan Suciu^3*, P.W. Wijermans²² and Michael Luebbert, MD²³

¹Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
²University Medical Center Groningen, Groningen, Netherlands
³EORTC Headquarters, Brussels, Belgium
⁴Department of Hematology, Radboud University Medical Centre, Nijmegen, Netherlands
⁵Klinik für Hämatologie, Universitätsklinikum Essen, Essen, Germany
⁶Institut d’Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen, France
⁷Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania
⁸Hematology, Oncology, Immunology, Philipps University, Marburg, Germany
⁹SC Ematologia Città della Salute e della Scienza Torino, Torino, Italy
¹⁰Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, University of Modena and Reggio Emilia, Azienda Ospedaliera Universitaria, Modena, Italy
¹¹Department of Hematology and Oncology, HELIOS Hospital Berlin-Buch, Berlin, Germany
¹²Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, "Sapienza" Università di Roma, Rome, Italy
¹³Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Center for Integrated Oncology Aachen Bonn Cologne, Duesseldorf (CIO ABCD), Aachen, Germany
¹⁴Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
¹⁵Department of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia
¹⁶Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹⁷Department of Internal Medicine, Reinier de Graaf Hospital, Delft, Netherlands
¹⁸Clinica Ematologica Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹⁹University of Liege, Liege, Belgium
²⁰Service d'Hématologie Clinique et de Thérapie cellulaire, Hôpital Saint Antoine, APHP, Paris, France
²¹USOD Ematologia e Trapianti, IRCSS Istituto Nazionale Tumori Regina Elena, Roma, Italy
²²Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
²³Department of Hematology, Oncology, and Stem-Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany

Jonathan Hyak, MD, MPH^1*, Deedra Nicolet, MS², Jessica Kohlschmidt, PhD³, Kellie J. Archer, PhD^4*, James S. Blachly, MD⁵, Karilyn T. Larkin, MD⁶, Bayard L. Powell, MD⁷, Jonathan E. Kolitz, MD⁸, Maria R. Baer, MD⁹, William G. Blum, MD¹⁰, Geoffrey L. Uy, MD¹¹, Wendy Stock, MD¹², Richard M. Stone, MD¹³, John C. Byrd, MD¹⁴, Krzysztof Mrózek, MD, PhD¹⁵, Ann-Kathrin Eisfeld, MD² and Alice S. Mims, MD⁵

¹The Ohio State University, Columbus, OH
²Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
³Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus
⁴Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁶Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁷Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC
⁸Monter Cancer Center, North Shore University Hospital and Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY
⁹University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹⁰Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹¹Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
¹²University of Chicago, Chicago, IL
¹³Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁴University of Cincinnati College of Medicine, Cincinnati, OH
¹⁵Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Rimal Ilyas, MBBS^1*, Isla McKerrow Johnson, MD¹, Kristen McCullough, PharmD², Aref Al-Kali, MD³, Hassan B. Alkhateeb, MD^3*, Kebede Begna, MD⁴, Abhishek A. Mangaonkar, MBBS³, Mark R. Litzow, MD³, William J. Hogan, MB, BCh³, Mithun V. Shah, MD, PhD³, Mrinal M. M. Patnaik, MD, MBBS³, Animesh Pardanani, MBBS, PhD ³, Ayalew Tefferi, MD³ and Naseema Gangat, MBBS³

¹Mayo Clinic, Rochester, MN
²Division of Pharmacology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Divison of Hematology, Mayo Clinic, Rochester, MN

Filip Ionescu, MD¹, David A. Sallman, MD², Kendra Sweet, MD², Rami S. Komrokji², Onyee Chan, MD³, Andrew Kuykendall, MD⁴, Eric Padron, MD², Rawan Faramand, MD⁵, Nelli Bejanyan, MD⁶, Farhad Khimani, MD^5*, Hany Elmariah, MD, MS⁷, Joseph Pidala, MD, PhD⁷, Asmita Mishra, MD⁷, Lia Perez, MD^7*, Taiga Nishihori, MD⁷ and Jeffrey E. Lancet, MD^8,9

¹Department of Hematology and Oncology, H. Lee Moffitt Cancer Center/University of South Florida, Tampa, FL
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
³Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Mofitt Cancer Center, Tampa, FL
⁵Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
⁷Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
⁸Department of Malignant Hematology, H. Lee Moffitt Cancer Ctr. %26 Rsrch. Institute, Tampa, FL
⁹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Sophia Gross^1*, Jana Ihlow^1,2*, Leonie Busack^1*, Kacper Adamiak^1*, Jens F. Schrezenmeier^1*, Julia Jesse^1*, Michaela Schwarz^1*, Anne Floercken^1*, Kathrin Rieger^3*, Jan Krönke^3*, Philipp le Coutre, MD⁴, Vivien Boldt^5*, Ann-Christin von Bruenneck^2*, David Horst^2*, Thomas Burmeister^1*, Igor Wolfgang Blau, MD^6*, Ulrich Keller^3*, Lars Bullinger, MD⁷ and Joerg Westermann¹

¹Department of Hematology, Oncology and Tumor Immunology, Campus Virchow-Clinic, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
²Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
³Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
⁴Department of Hematology, Oncology and Tumor Immunology, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany
⁵Department of Tumor Cytogenetics, Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
⁶Department of BMT, Clinic of Hematology, Oncology and Tumorimmunology, University Medicine Berlin, Berlin, Germany
⁷Department of Hematology, Oncology, and Tumor Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany

Naveen Pemmaraju, MD¹, Hagop Kantarjian, MD², Joseph D. Khoury, MD, FCAP³, Nitin Jain, MD⁴, Muzaffar H Qazilbash, MD⁵, Sanam Loghavi, MD⁶, Sherry A. Pierce, BSN, BA^1*, Keyur P. Patel, MBBS, PhD⁶, Guillermo Garcia-Manero, MD⁷, Elias Jabbour, MD¹, Naval Daver, MD⁸, Gautam Borthakur, MD¹ and Marina Konopleva, MD^9*

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Nebraska Medical Center, Omaha, NE
⁴Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁸MD Anderson Cancer Center, Houston, TX
⁹Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY